A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers

Name: A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers
Published: 2022
License: Public Domain

Hillhurst Biopharmaceuticals, Inc. · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

anemia co genetic-diseases

anemia, sickle cell, anemia, hemolytic, congenital, anemia, hemolytic, anemia, hematologic diseases, hemoglobinopathies, genetic diseases, inborn, carbon monoxide, co, heme oxygenase, ho-1, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers

Related documents